Oncotype DX Medical Laboratory Testing Notice of Intent to Sole Source

The Department of Veteran Affairs, Veterans Health Administration, Network Contracting Office 6, Hampton VA 23667, intends to negotiate a new BPA, sole source, firm-fixed price contract for the Durham VAMC laboratories to Exact Sciences Corporation for Oncotype DX Breast Tests with 41 U.S.C. §3304(a)(1) as implemented by FAR 6.302-1 Only One Responsible Source. This is not a request for competitive offers and no solicitation is available.

Market research has determined that these items are highly specialized, are only available from a single source without an unacceptable delay or duplication of cost and no other type of items will satisfy agency requirements. The Government intends to award the contract with an effective date of 06 March 2024 to Exact Sciences Corporation, 5505 Endeavor Lane, Madison, WI 53719;

Unique Entity ID: NGBXEJX5GLE9. This is a Brand-Name Only requirement for Durham VAMC laboratories. The Durham VAMC require supplies and services that are unique and highly specialized The Oncotype test use mRNA, real time RT-PCR of 21 genes to process and report the specific tumor s recurrence score, which details the composition of an individual s specific tumor. The required services are available on FSS contract and not available through any other distributor, SDVOSB or VOSB.

No other supplies or services will satisfy agency requirements per FAR 13.106-1(b)(1). This synopsis announcement is being issued for information purposes only and does not constitute a solicitation or request for competitive proposals.

If a firm believes it is capable of meeting the Government's requirement, it may identify its interest and capability to the contract specialist within three (3) calendar days of this publication by contacting Daleta Coles via e-mail at daleta.coles@va.gov Telephone inquiries will not be accepted. This announcement closes 27 February 2024 at 11:00 AM EST. Those interested firms must indicate whether they are large, small, small-disadvantaged, 8(a) or woman owned business and whether they are U.S. or foreign owned.

Respondents who submit proprietary data shall clearly mark the data with appropriate markings. The Government will not pay for any information submitted as a result of this synopsis. This synopsis shall not be construed as an obligation on the part of the Government to acquire any products or services.

Reference RFP 36C24624Q0349 in all replies